{"cik":"0001842952","entityName":"CONTEXT THERAPEUTICS INC.","facts":{"dei":{"EntityCommonStockSharesOutstanding":{"label":"Entity Common Stock, Shares Outstanding","description":"Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.","units":{"shares":[{"end":"2021-11-29","val":10963966,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q4I"}]}}},"us-gaap":{"AccountsPayableCurrent":{"label":"Accounts Payable, Current","description":"Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":2707861,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":3083420,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"AccruedLiabilitiesCurrent":{"label":"Accrued Liabilities, Current","description":"Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).","units":{"USD":[{"end":"2020-12-31","val":955989,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1325194,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"AdditionalPaidInCapital":{"label":"Additional Paid in Capital","description":"Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.","units":{"USD":[{"end":"2020-12-31","val":1876159,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2948294,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock":{"label":"Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock","description":"Amount of decrease (increase) in additional paid in capital (APIC) for the increase in carrying amount of redeemable preferred stock.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":-13000,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q1"},{"start":"2020-04-01","end":"2020-06-30","val":-82000,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q2"},{"start":"2020-07-01","end":"2020-09-30","val":1000,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-04-01","end":"2021-06-30","val":53330,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q2"}]}},"AdjustmentsToAdditionalPaidInCapitalWarrantIssued":{"label":"Adjustments to Additional Paid in Capital, Warrant Issued","description":"Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.","units":{"USD":[{"start":"2021-02-01","end":"2021-02-28","val":100000,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q1I"}]}},"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount":{"label":"Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount","description":"Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":153273,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":3644431,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":5787116,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":5787116,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"Assets":{"label":"Assets","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":467340,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2259304,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"AssetsCurrent":{"label":"Assets, Current","description":"Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.","units":{"USD":[{"end":"2020-12-31","val":349709,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":437531,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"CashAndCashEquivalentsAtCarryingValue":{"label":"Cash and Cash Equivalents, at Carrying Value","description":"Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.","units":{"USD":[{"end":"2020-12-31","val":341037,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":419152,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents","description":"Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"end":"2019-12-31","val":226603,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2019Q4I"},{"end":"2020-09-30","val":167062,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3I"},{"end":"2020-12-31","val":341037,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":419152,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect":{"label":"Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect","description":"Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-59541,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":78115,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"ClassOfWarrantOrRightOutstanding":{"label":"Class of Warrant or Right, Outstanding","description":"Number of warrants or rights outstanding.","units":{"shares":[{"end":"2021-09-30","val":480415,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"CommonStockParOrStatedValuePerShare":{"label":"Common Stock, Par or Stated Value Per Share","description":"Face amount or stated value per share of common stock.","units":{"USD/shares":[{"end":"2020-12-31","val":0.001,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0.001,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"CommonStockSharesAuthorized":{"label":"Common Stock, Shares Authorized","description":"The maximum number of common shares permitted to be issued by an entity's charter and bylaws.","units":{"shares":[{"end":"2021-09-30","val":100000000,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"CommonStockSharesIssued":{"label":"Common Stock, Shares, Issued","description":"Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.","units":{"shares":[{"end":"2020-12-31","val":331789,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":348531,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"CommonStockSharesOutstanding":{"label":"Common Stock, Shares, Outstanding","description":"Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.","units":{"shares":[{"end":"2020-12-31","val":331789,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":348531,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"CommonStockValue":{"label":"Common Stock, Value, Issued","description":"Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.","units":{"USD":[{"end":"2020-12-31","val":332,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":348,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"ConvertibleDebtCurrent":{"label":"Convertible Debt, Current","description":"The portion of the carrying value of long-term convertible debt as of the balance sheet date that is scheduled to be repaid within one year or in the normal operating cycle if longer. Convertible debt is a financial instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.","units":{"USD":[{"end":"2020-12-31","val":5829292,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"DeferredCosts":{"label":"Deferred Costs, Noncurrent","description":"Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.","units":{"USD":[{"end":"2020-12-31","val":117631,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1821773,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"DeferredCostsCurrentAndNoncurrent":{"label":"Deferred Costs","description":"The carrying amount of deferred costs.","units":{"USD":[{"end":"2020-12-31","val":100000,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":1800000,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"DilutiveSecuritiesEffectOnBasicEarningsPerShareOther":{"label":"Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities","description":"Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise of dilutive convertible securities excluding adjustments related to ESOP convertible preferred stock, stock options, and restrictive stock units.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-9231838,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"EarningsPerShareBasic":{"label":"Earnings Per Share, Basic","description":"The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":4.04,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":-2.52,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-20.74,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":-4,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"EarningsPerShareDiluted":{"label":"Earnings Per Share, Diluted","description":"The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":-3.35,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":-2.52,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-20.74,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":-4,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions":{"label":"Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount","description":"Amount of cost to be recognized for option under share-based payment arrangement.","units":{"USD":[{"end":"2021-09-30","val":1400000,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"FairValueAdjustmentOfWarrants":{"label":"Fair Value Adjustment of Warrants","description":"Amount of expense (income) related to adjustment to fair value of warrant liability.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":371895,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"GainsLossesOnExtinguishmentOfDebt":{"label":"Gain (Loss) on Extinguishment of Debt","description":"Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":125577,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"GeneralAndAdministrativeExpense":{"label":"General and Administrative Expense","description":"The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":755962,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":182389,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":1834645,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":828464,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"IncreaseDecreaseInAccountsPayable":{"label":"Increase (Decrease) in Accounts Payable","description":"The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":356255,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":-179199,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"IncreaseDecreaseInAccruedLiabilities":{"label":"Increase (Decrease) in Accrued Liabilities","description":"The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":399196,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":20021,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets":{"label":"Increase (Decrease) in Prepaid Expense and Other Assets","description":"Amount of increase (decrease) in prepaid expenses, and assets classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-151,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":9707,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"InterestExpense":{"label":"Interest Expense","description":"Amount of the cost of borrowed funds accounted for as interest expense.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":566790,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":95211,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":64555,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":1261,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"Liabilities":{"label":"Liabilities","description":"Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.","units":{"USD":[{"end":"2020-12-31","val":9617196,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":4408614,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"LiabilitiesAndStockholdersEquity":{"label":"Liabilities and Equity","description":"Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.","units":{"USD":[{"end":"2020-12-31","val":467340,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":2259304,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"LiabilitiesCurrent":{"label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":9548156,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":4408614,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"LongTermNotesPayable":{"label":"Notes Payable, Noncurrent","description":"Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.","units":{"USD":[{"end":"2020-12-31","val":69040,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"NetCashProvidedByUsedInFinancingActivities":{"label":"Net Cash Provided by (Used in) Financing Activities","description":"Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":799054,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":4165918,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"NetCashProvidedByUsedInInvestingActivities":{"label":"Net Cash Provided by (Used in) Investing Activities","description":"Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":-250000,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"NetCashProvidedByUsedInOperatingActivities":{"label":"Net Cash Provided by (Used in) Operating Activities","description":"Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-858595,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":-3837803,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"NetIncomeLoss":{"label":"Net Income (Loss) Attributable to Parent","description":"The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":826480,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q1"},{"start":"2020-04-01","end":"2020-06-30","val":7478971,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q2"},{"start":"2020-01-01","end":"2020-09-30","val":7429214,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":-876237,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":-892049,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q1"},{"start":"2021-04-01","end":"2021-06-30","val":-5030164,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q2"},{"start":"2021-01-01","end":"2021-09-30","val":-7365005,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":-1442792,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"NetIncomeLossAvailableToCommonStockholdersBasic":{"label":"Net Income (Loss) Available to Common Stockholders, Basic","description":"Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1407875,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":-876237,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-7365005,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":-1442792,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"NetIncomeLossAvailableToCommonStockholdersDiluted":{"label":"Net Income (Loss) Available to Common Stockholders, Diluted","description":"Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-7823963,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":-876237,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-7365005,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":-1442792,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"NonoperatingIncomeExpense":{"label":"Nonoperating Income (Expense)","description":"The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":124148,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":126531,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"NotesPayableCurrent":{"label":"Notes Payable, Current","description":"Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.","units":{"USD":[{"end":"2020-12-31","val":55014,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"NumberOfOperatingSegments":{"label":"Number of Operating Segments","description":"Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.","units":{"segment":[{"start":"2021-01-01","end":"2021-09-30","val":1,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"OperatingIncomeLoss":{"label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":-1802624,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":-651060,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":-7433915,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":-1568062,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"PaidInKindInterest":{"label":"Paid-in-Kind Interest","description":"Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":566790,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":64555,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"PaymentsOfStockIssuanceCosts":{"label":"Payments of Stock Issuance Costs","description":"The cash outflow for cost incurred directly with the issuance of an equity security.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":816917,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"PaymentsToAcquireInProcessResearchAndDevelopment":{"label":"Payments to Acquire in Process Research and Development","description":"The cash outflows from the purchase of net carrying value allocated to in-process research and development costs and materials acquired in a business combination.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":250000,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"PrepaidExpenseAndOtherAssetsCurrent":{"label":"Prepaid Expense and Other Assets, Current","description":"Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.","units":{"USD":[{"end":"2020-12-31","val":8672,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":18379,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"ProceedsFromConvertibleDebt":{"label":"Proceeds from Convertible Debt","description":"The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":25000,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"ProceedsFromIssuanceOfOtherLongTermDebt":{"label":"Proceeds from Issuance of Other Long-term Debt","description":"Amount of cash inflow from issuance of long-term debt classified as other.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":124054,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost":{"label":"Research and Development Expense (Excluding Acquired in Process Cost)","description":"The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":1046662,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":468671,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":2511438,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":739598,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"ResearchAndDevelopmentInProcess":{"label":"Research and Development in Process","description":"The amount of purchased research and development assets that are acquired in a business combination have no alternative future use and are therefore written off in the period of acquisition.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":3087832,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"RetainedEarningsAccumulatedDeficit":{"label":"Retained Earnings (Accumulated Deficit)","description":"The cumulative amount of the reporting entity's undistributed earnings or deficit.","units":{"USD":[{"end":"2020-12-31","val":-18797570,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":-26162575,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"ShareBasedCompensation":{"label":"Share-based Payment Arrangement, Noncash Expense","description":"Amount of noncash expense for share-based payment arrangement.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":188427,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":306699,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number","description":"The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.","units":{"shares":[{"end":"2021-09-30","val":90765,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price","description":"The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.","units":{"USD/shares":[{"end":"2021-09-30","val":8.08,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross","description":"Gross number of share options (or share units) granted during the period.","units":{"shares":[{"start":"2021-01-01","end":"2021-09-30","val":411607,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value","description":"The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.","units":{"USD/shares":[{"start":"2020-01-01","end":"2020-09-30","val":9.34,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":3.76,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number","description":"Number of options outstanding, including both vested and non-vested options.","units":{"shares":[{"end":"2020-12-31","val":24830,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":436437,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price","description":"Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.","units":{"USD/shares":[{"end":"2020-12-31","val":17.84,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":5.69,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number","description":"Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.","units":{"shares":[{"end":"2021-09-30","val":436437,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price","description":"Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.","units":{"USD/shares":[{"end":"2021-09-30","val":5.69,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice":{"label":"Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price","description":"Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.","units":{"USD/shares":[{"start":"2021-01-01","end":"2021-09-30","val":4.95,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"StockholdersEquity":{"label":"Stockholders' Equity Attributable to Parent","description":"Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.","units":{"USD":[{"end":"2019-12-31","val":-23960756,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2019Q4I"},{"end":"2020-03-31","val":-22994309,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q1I"},{"end":"2020-06-30","val":-15394853,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q2I"},{"end":"2020-09-30","val":-16217752,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3I"},{"end":"2020-12-31","val":-16921079,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-03-31","val":-17478072,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q1I"},{"end":"2021-06-30","val":-22304859,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q2I"},{"end":"2021-09-30","val":-23213933,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"StockIssued1":{"label":"Stock Issued","description":"The fair value of stock issued in noncash financing activities.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-01-01","end":"2021-09-30","val":2837832,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"StockIssuedDuringPeriodSharesIssuedForServices":{"label":"Stock Issued During Period, Shares, Issued for Services","description":"Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":7512,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"}]}},"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities":{"label":"Stock Issued During Period, Value, Conversion of Convertible Securities","description":"The gross value of stock issued during the period upon the conversion of convertible securities.","units":{"USD":[{"start":"2021-01-01","end":"2021-03-31","val":137497,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q1"}]}},"StockIssuedDuringPeriodValueShareBasedCompensationGross":{"label":"Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture","description":"Value, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).","units":{"USD":[{"start":"2020-01-01","end":"2020-03-31","val":126967,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q1"},{"start":"2020-04-01","end":"2020-06-30","val":30642,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q2"},{"start":"2020-07-01","end":"2020-09-30","val":30818,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-03-31","val":25513,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q1"},{"start":"2021-04-01","end":"2021-06-30","val":119363,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q2"},{"start":"2021-07-01","end":"2021-09-30","val":161823,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"TemporaryEquityCarryingAmountAttributableToParent":{"label":"Temporary Equity, Carrying Amount, Attributable to Parent","description":"Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.","units":{"USD":[{"end":"2020-12-31","val":7771223,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":21064623,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"TemporaryEquityParOrStatedValuePerShare":{"label":"Temporary Equity, Par or Stated Value Per Share","description":"Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.","units":{"USD/shares":[{"end":"2020-12-31","val":0.001,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q4I"},{"end":"2021-09-30","val":0.001,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3I"}]}},"UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic":{"label":"Undistributed Earnings (Loss) Allocated to Participating Securities, Basic","description":"Amount of undistributed earnings (loss) allocated to participating securities for the basic earnings (loss) per share or per unit calculation under the two-class method.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":6021339,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted":{"label":"Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted","description":"Amount of undistributed earnings (loss) allocated to participating securities for the diluted earnings (loss) per share or per unit calculation under the two-class method.","units":{"USD":[{"start":"2020-01-01","end":"2020-09-30","val":6021339,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"WeightedAverageNumberDilutedSharesOutstandingAdjustment":{"label":"Weighted Average Number Diluted Shares Outstanding Adjustment","description":"The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":1988679,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":0,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"WeightedAverageNumberOfDilutedSharesOutstanding":{"label":"Weighted Average Number of Shares Outstanding, Diluted","description":"The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":2337027,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":348382,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":355087,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":361067,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}},"WeightedAverageNumberOfSharesOutstandingBasic":{"label":"Weighted Average Number of Shares Outstanding, Basic","description":"Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.","units":{"shares":[{"start":"2020-01-01","end":"2020-09-30","val":348348,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2020-07-01","end":"2020-09-30","val":348382,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2020Q3"},{"start":"2021-01-01","end":"2021-09-30","val":355087,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02"},{"start":"2021-07-01","end":"2021-09-30","val":361067,"accn":"0001842952-21-000015","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-12-02","frame":"CY2021Q3"}]}}}}}